Anika Therapeutics, Inc. (NASDAQ:ANIK) Q1 2026 Earnings Call Transcript April 29, 2026
Anika Therapeutics, Inc. beats earnings expectations. Reported EPS is $0.27, expectations were $-0.07.
Operator: Good morning, ladies and gentlemen, and welcome to the Anika’s First Quarter Earnings Conference Call. I will now turn the call over to Mr. Matt Hall, Executive Director, Corporate Development and Investor Relations. Please go ahead.
Matthew Hall: Good morning, and thank you for joining us for...
